🌊 Social🇮🇳 India
HIV Prevention Drug Could Save Millions, But USAID Cuts Are Blocking Access
The Guardian·Saturday, 1 August 2026
A new injectable PrEP drug shows strong promise for preventing HIV infections globally, but experts say cuts to USAID funding have dramatically reduced investment in HIV prevention worldwide. The drug's potential is being undermined by shrinking financial support for the programmes that would deliver it.
Why It Matters
India has one of the world's largest populations living with HIV, and relies on international health funding and drug access programmes — USAID cuts directly affect availability of prevention tools here.
🔒 Potential Impact + source link
Subscribe to unlock the impact analysis and original source for every story.
More from Social
- Japan Earthquake Death Toll Climbs to 30 as Heat and Aftershocks Slow Rescue
- DRC Ebola Outbreak Is Now the Fastest-Spreading in the Virus's Known History
- 57 Dead as 50,000 Migrants Storm Spanish Enclave of Ceuta from Morocco in 24 Hours
- Trump Announces Deal for Hamas to Disarm and Israeli Forces to Leave Gaza